# A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities

> **NCT07008456** · PHASE2 · RECRUITING · sponsor: **Aphaia Pharma US LLC** · enrollment: 102 (estimated)

## Conditions studied

- Obese With Comorbidities
- Obese Patients (BMI ≥ 30 kg/m²)

## Interventions

- **DRUG:** APHD-012
- **DRUG:** APHD-002
- **DRUG:** APHP-012
- **DRUG:** APHP-002

## Key facts

- **NCT ID:** NCT07008456
- **Lead sponsor:** Aphaia Pharma US LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-12
- **Primary completion:** 2026-07
- **Final completion:** 2026-07
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2025-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07008456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07008456, "A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07008456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*